Silk Road Medical Inc. (SILK) Tops Q4 EPS by 4c

Silk Road Medical Inc. (NASDAQ: SILK) reported Q4 EPS of ($0.34), $0.04 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $37.35 million.

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Reliance Industries (RELIANCE:IN) PT Raised to INR1,710 at Jefferies
• Morgan Stanley Downgrades Nordea Bank Abp (NDA:SS) (NRDBY) to Equalweight